Literature DB >> 31420310

Quantifying physical activity in early Parkinson disease using a commercial activity monitor.

Sujata Pradhan1, Valerie E Kelly2.   

Abstract

INTRODUCTION: Physical inactivity in Parkinson disease (PD) has an impact on motor and non-motor symptoms of the disease. It is unclear whether this decline in physical activity occurs early in the disease, in addition to any decline due to aging, and whether commercial activity monitors can be used to self-monitor physical activity levels in this population.
OBJECTIVE: To compare the quantity and intensity of physical activity (PA), as measured by commercial activity monitors, in people with mild PD and healthy older adults (HOA). A secondary objective was to assess adherence and user experience with wearing the activity monitoring device.
METHODS: An observational descriptive study design examined PA levels over a 14-day period using commercially-available activity monitors (Fitbit Charge HR).
RESULTS: Individuals with PD (n = 30) and HOA (n = 30) both demonstrated high adherence with wear time (PD = 13.8 [0.5] days, HOA = 13.9 [0.4] days, p = 0.55). People with PD took fewer steps per day than HOA (PD = 6416.9 (2795.5), HOA = 11441.3 (3932.1), p < 0.001). Compared to HOA, individuals with PD spent fewer minutes per day engaged in moderate to vigorous intensity activity (PD = 33.0 (22.5), HOA = 72.0(37.3), p < 0.001) and more minutes per day sedentary (PD = 803.74 (154.9), HOA = 578.26 (103.7), p < 0.001). Both groups reported that ease of use and satisfaction with the activity monitor were high.
CONCLUSIONS: People with mild PD demonstrated reduced quantity and intensity of PA compared to HOA. Both the PD and the HOA groups had good adherence wearing a commercial activity monitor that provided feedback regarding activity levels.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson disease; Physical activity

Mesh:

Year:  2019        PMID: 31420310      PMCID: PMC7065569          DOI: 10.1016/j.parkreldis.2019.08.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  26 in total

1.  Capturing ambulatory activity decline in Parkinson's disease.

Authors:  James T Cavanaugh; Terry D Ellis; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Leland E Dibble
Journal:  J Neurol Phys Ther       Date:  2012-06       Impact factor: 3.649

Review 2.  Daily step goal of 10,000 steps: a literature review.

Authors:  Bernard C K Choi; Anita W P Pak; Jerome C L Choi; Elaine C L Choi
Journal:  Clin Invest Med       Date:  2007       Impact factor: 0.825

3.  Revisiting "how many steps are enough?".

Authors:  Catrine Tudor-Locke; Yoshiro Hatano; Robert P Pangrazi; Minsoo Kang
Journal:  Med Sci Sports Exerc       Date:  2008-07       Impact factor: 5.411

4.  Population representative gait speed and its determinants.

Authors:  Richard W Bohannon
Journal:  J Geriatr Phys Ther       Date:  2008       Impact factor: 3.381

5.  Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.

Authors:  Guoen Cai; Yujie Huang; Shan Luo; Zhirong Lin; Houde Dai; Qinyong Ye
Journal:  Neurol Sci       Date:  2017-06-28       Impact factor: 3.307

6.  On the mini-BESTest: scoring and the reporting of total scores.

Authors:  Laurie King; Fay Horak
Journal:  Phys Ther       Date:  2013-04

7.  Ambulatory activity in incident Parkinson's: more than meets the eye?

Authors:  Sue Lord; Alan Godfrey; Brook Galna; Dadirayi Mhiripiri; David Burn; Lynn Rochester
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

8.  Daily ambulatory activity levels in idiopathic Parkinson disease.

Authors:  Frank M Skidmore; Chad A Mackman; Breckon Pav; Lisa M Shulman; Cyndi Garvan; Richard F Macko; Kenneth M Heilman
Journal:  J Rehabil Res Dev       Date:  2008

9.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

10.  Utilization of rehabilitation therapy services in Parkinson disease in the United States.

Authors:  Michelle E Fullard; Dylan P Thibault; Andrew Hill; Joellyn Fox; Danish E Bhatti; Michelle A Burack; Nabila Dahodwala; Elizabeth Haberfeld; Drew S Kern; Olga S Klepitskava; Enrique Urrea-Mendoza; Phillip Myers; Jay Nutt; Miriam R Rafferty; Jason M Schwalb; Lisa M Shulman; Allison W Willis
Journal:  Neurology       Date:  2017-08-23       Impact factor: 9.910

View more
  11 in total

Review 1.  Sarcopenia and nervous system disorders.

Authors:  Jie Yang; Feifei Jiang; Ming Yang; Zhizhi Chen
Journal:  J Neurol       Date:  2022-07-13       Impact factor: 6.682

Review 2.  Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review.

Authors:  Mathias Baptiste Correno; Clint Hansen; Thomas Carlin; Nicolas Vuillerme
Journal:  Sensors (Basel)       Date:  2022-06-16       Impact factor: 3.847

Review 3.  Digital Technology in Movement Disorders: Updates, Applications, and Challenges.

Authors:  Jamie L Adams; Karlo J Lizarraga; Emma M Waddell; Taylor L Myers; Stella Jensen-Roberts; Joseph S Modica; Ruth B Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-03       Impact factor: 6.030

Review 4.  Wearable GPS and Accelerometer Technologies for Monitoring Mobility and Physical Activity in Neurodegenerative Disorders: A Systematic Review.

Authors:  Mícheál Ó Breasail; Bijetri Biswas; Matthew D Smith; Md Khadimul A Mazhar; Emma Tenison; Anisha Cullen; Fiona E Lithander; Anne Roudaut; Emily J Henderson
Journal:  Sensors (Basel)       Date:  2021-12-10       Impact factor: 3.576

5.  A real-world study of wearable sensors in Parkinson's disease.

Authors:  Jamie L Adams; Karthik Dinesh; Christopher W Snyder; Mulin Xiong; Christopher G Tarolli; Saloni Sharma; E Ray Dorsey; Gaurav Sharma
Journal:  NPJ Parkinsons Dis       Date:  2021-11-29

6.  The Use of Consumer Wearable Physical Activity Monitors in Clinical Populations with Functional Limitations.

Authors:  Julian Martinez; Taylor M Gordon; Scott J Strath
Journal:  J Phys Med Rehabil       Date:  2021

Review 7.  The Impact of Wearable Technologies in Health Research: Scoping Review.

Authors:  Sophie Huhn; Miriam Axt; Hanns-Christian Gunga; Martina Anna Maggioni; Stephen Munga; David Obor; Ali Sié; Valentin Boudo; Aditi Bunker; Rainer Sauerborn; Till Bärnighausen; Sandra Barteit
Journal:  JMIR Mhealth Uhealth       Date:  2022-01-25       Impact factor: 4.773

8.  Clinical correlates of sarcopenia and falls in Parkinson's disease.

Authors:  Danielle Pessoa Lima; Samuel Brito de Almeida; Janine de Carvalho Bonfadini; João Rafael Gomes de Luna; Madeleine Sales de Alencar; Edilberto Barreira Pinheiro-Neto; Antonio Brazil Viana-Júnior; Samuel Ranieri Oliveira Veras; Manoel Alves Sobreira-Neto; Jarbas de Sá Roriz-Filho; Pedro Braga-Neto
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

9.  Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.

Authors:  Brenda Jeng; Katie L J Cederberg; Byron Lai; Jeffer E Sasaki; Marcas M Bamman; Robert W Motl
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

10.  Acceptability and Preliminary Results of Technology-Assisted Balance Training in Parkinson's Disease.

Authors:  Elvira Maranesi; Valentina Di Donna; Giuseppe Pelliccioni; Valentina Cameriere; Elisa Casoni; Renato Baldoni; Marco Benadduci; Nadia Rinaldi; Lorenzo Fantechi; Cinzia Giammarchi; Riccardo Luzi; Paolo Pelliccioni; Mirko Di Rosa; Pietro Scendoni; Giovanni Renato Riccardi; Roberta Bevilacqua
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.